Selective COX-2 inhibitors and nephrotoxicity

被引:8
|
作者
Balasubramaniam, J [1 ]
机构
[1] Kidney Care Ctr, Tirunelveli, Tamil Nadu, India
关键词
D O I
10.1053/ajkd.2000.16213
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:675 / 676
页数:2
相关论文
共 50 条
  • [41] COX-2 selective inhibitors - important lessons learned
    Maxwell, SRJ
    Webb, DJ
    LANCET, 2005, 365 (9458): : 449 - 451
  • [42] Clinical pharmacology of novel selective COX-2 inhibitors
    Tacconelli, S
    Capone, ML
    Patrignani, P
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 589 - 601
  • [43] Aspirin, selective COX-2 inhibitors and gastrotolerance - Foreword
    Fiorucci, S
    Morelli, A
    Porro, GB
    DIGESTIVE AND LIVER DISEASE, 2001, 33 : S1 - S1
  • [45] Risk of hyperkalemia associated with selective COX-2 inhibitors
    Aljadhey, Hisham
    Tu, Wanzhu
    Hansen, Richard A.
    Blalock, Susan
    Brater, Craig
    Murray, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1194 - 1198
  • [46] The future of NSAID therapy: selective COX-2 inhibitors
    Vane, JR
    Botting, RM
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (01) : 7 - 9
  • [48] Design of peptides and peptidomimetics as COX-2 selective inhibitors
    Kothekar, V
    Sahi, S
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 577 (2-3): : 107 - 120
  • [49] NSAID COX-2 selective inhibitors: hopes and incertitudes
    Bannwarth, B
    PRESSE MEDICALE, 1999, 28 (22): : 1180 - 1181
  • [50] Selective COX-2 inhibitors and risk of myocardial infarction
    Krötz, F
    Schiele, TM
    Klauss, V
    Sohn, HY
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 (04) : 312 - 324